CAMP4 Historical Income Statement
| CAMP Stock | USD 1.59 0.07 4.22% |
Historical analysis of CAMP4 THERAPEUTICS income statement accounts such as Total Revenue of 619.4 K, Gross Profit of 619.4 K or Other Operating Expenses of 51.1 M can show how well CAMP4 THERAPEUTICS PORATION performed in making a profits. Evaluating CAMP4 THERAPEUTICS income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of CAMP4 THERAPEUTICS's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining CAMP4 THERAPEUTICS latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether CAMP4 THERAPEUTICS is a good buy for the upcoming year.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CAMP4 THERAPEUTICS PORATION. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. About CAMP4 Income Statement Analysis
CAMP4 THERAPEUTICS Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to CAMP4 THERAPEUTICS shareholders. The income statement also shows CAMP4 investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
CAMP4 THERAPEUTICS Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts CAMP4 THERAPEUTICS generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of CAMP4 THERAPEUTICS. It is also known as CAMP4 THERAPEUTICS overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Cost Of Revenue
Cost of Revenue is found on CAMP4 THERAPEUTICS income statement and represents the costs associated with goods and services CAMP4 THERAPEUTICS provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from CAMP4 THERAPEUTICS's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into CAMP4 THERAPEUTICS current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CAMP4 THERAPEUTICS PORATION. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. At this time, CAMP4 THERAPEUTICS's Total Other Income Expense Net is relatively stable compared to the past year. As of 07/23/2025, Research Development is likely to grow to about 40.8 M, while Gross Profit is likely to drop slightly above 619.4 K.
| 2022 | 2023 | 2024 | 2025 (projected) | Total Revenue | 294.9M | 186.2M | 652K | 619.4K | Depreciation And Amortization | 21.8M | 1.7M | 2.0M | 1.9M |
CAMP4 THERAPEUTICS income statement Correlations
Click cells to compare fundamentals
CAMP4 THERAPEUTICS Account Relationship Matchups
High Positive Relationship
High Negative Relationship
CAMP4 THERAPEUTICS income statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Depreciation And Amortization | 22.0M | 22.8M | 21.8M | 1.7M | 2.0M | 1.9M | |
| Total Revenue | 308.6M | 295.8M | 294.9M | 186.2M | 652K | 619.4K | |
| Gross Profit | 122.4M | 121.9M | 109.0M | 67.0M | 652K | 619.4K | |
| Other Operating Expenses | 312.1M | 308.7M | 315.0M | 195.0M | 53.7M | 51.1M | |
| Operating Income | (3.9M) | (15.3M) | (21.5M) | (8.7M) | (53.1M) | (50.4M) | |
| Ebit | (3.9M) | (15.3M) | (21.5M) | (53.1M) | (47.8M) | (45.4M) | |
| Ebitda | 18.1M | 7.5M | 276K | (8.7M) | (51.4M) | (48.8M) | |
| Cost Of Revenue | 186.2M | 174.0M | 185.9M | 119.3M | 137.1M | 107.4M | |
| Total Operating Expenses | 125.9M | 134.8M | 129.1M | 75.7M | 53.7M | 52.6M | |
| Income Before Tax | (20.6M) | (30.1M) | (31.3M) | (92.7M) | (51.8M) | (49.2M) | |
| Total Other Income Expense Net | (16.7M) | (14.7M) | (9.9M) | (84.0M) | 1.3M | 1.4M | |
| Net Income | (21.2M) | (31.1M) | (32.5M) | (93.3M) | (51.8M) | (49.2M) | |
| Income Tax Expense | 561K | 1.1M | 1.2M | (525K) | (603.8K) | (573.6K) | |
| Research Development | 25.8M | 28.4M | 24.6M | 14.7M | 38.8M | 40.8M | |
| Interest Expense | 15.5M | 15.3M | 6.3M | 4.7M | 5.4M | 7.7M | |
| Selling General Administrative | 49.1M | 52.3M | 51.8M | 31.5M | 14.9M | 14.2M | |
| Selling And Marketing Expenses | 46.2M | 48.6M | 47.4M | 29.5M | 34.0M | 34.2M |
Pair Trading with CAMP4 THERAPEUTICS
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CAMP4 THERAPEUTICS position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CAMP4 THERAPEUTICS will appreciate offsetting losses from the drop in the long position's value.Moving against CAMP4 Stock
| 0.75 | WF | Woori Financial Group Earnings Call Today | PairCorr |
| 0.74 | PFE | Pfizer Inc | PairCorr |
| 0.72 | BAC-PL | Bank of America | PairCorr |
| 0.71 | KMDA | Kamada | PairCorr |
| 0.7 | SHG | Shinhan Financial Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to CAMP4 THERAPEUTICS could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CAMP4 THERAPEUTICS when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CAMP4 THERAPEUTICS - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CAMP4 THERAPEUTICS PORATION to buy it.
The correlation of CAMP4 THERAPEUTICS is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CAMP4 THERAPEUTICS moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CAMP4 THERAPEUTICS moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CAMP4 THERAPEUTICS can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for CAMP4 Stock Analysis
When running CAMP4 THERAPEUTICS's price analysis, check to measure CAMP4 THERAPEUTICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CAMP4 THERAPEUTICS is operating at the current time. Most of CAMP4 THERAPEUTICS's value examination focuses on studying past and present price action to predict the probability of CAMP4 THERAPEUTICS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CAMP4 THERAPEUTICS's price. Additionally, you may evaluate how the addition of CAMP4 THERAPEUTICS to your portfolios can decrease your overall portfolio volatility.